Purity: > 90% by SDS PAGE Format: Liquid in 20 mM Tris pH 8.0,1 mM DTT, 2 mM EDTA, 10% glycerol . Estrogen receptor binding site associated antigen 9, also known as EBAG9, is a type III transmembrane protein that is predominantly located in the Golgi. This protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers, such as advanced breast and prostate cancers. As the EBAG9 acts to inhibit the growth of receptor-binding cells and induced apoptosis of immune cells, cancer cells might evade immune surveillance. So immunodetection of EBAG9 expression can be a negative prognostic indicator. Recombinant human EBAG9 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques.
Size
0.5mg, 100ug, 20ug
Concentration
n/a
Applications
SDS-PAGE
Other Names
Estrogen receptor binding site associated antigen 9, EB9, PDAF, RCAS1, Estrogen receptor binding site associated antigen 9, EBAG9, Estrogen receptor binding site associated, antigen 9 BAG9, Cancer associated surface antigen, Cancer associated surface antigen RCAS1, EBAG 9, Estrogen receptor binding fragment associated gene 9 protein, PDAF, RCAS 1, RCAS1, Receptor binding cancer antigen expressed on SiSo cells.